Necker-Enfants Malades Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2023

  1. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis

    Frontiers in Physiology

  2. Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey

    Pediatric Nephrology, Vol. 38, Núm. 9, pp. 3035-3042

  3. Sudden-Onset Disaster Mass-Casualty Incident Response: A Modified Delphi Study on Triage, Prehospital Life Support, and Processes

    Prehospital and Disaster Medicine, Vol. 38, Núm. 5, pp. 570-580

2022

  1. Kidneys also speak Spanish: Initiatives towards standardisation of our nephrology nomenclature

    Nefrologia, Vol. 42, Núm. 3, pp. 223-232

  2. Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 12, pp. 2474-2486

2021

  1. Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism

    Osteoporosis International, Vol. 32, Núm. 12, pp. 2397-2405

  2. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 1, pp. 42-59

  3. The Non-invasive Diagnosis of Bone Disorders in CKD

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 512-527

2019

  1. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

    Nature Reviews Nephrology, Vol. 15, Núm. 7, pp. 435-455

  2. Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network

    Scientific Reports, Vol. 9, Núm. 1

  3. Management of bone disease in cystinosis: Statement from an international conference

    Journal of Inherited Metabolic Disease, Vol. 42, Núm. 5, pp. 1019-1029

  4. Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications

    Nefrologia

  5. Treatment and long-Term outcome in primary distal renal tubular acidosis

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 6, pp. 981-991

2018

  1. Osteoporosis, bone mineral density and CKD–MBD complex (I): Diagnostic considerations

    Nefrologia

2003

  1. Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes

    Diabetologia, Vol. 46, Núm. 9, pp. 1291-1295

2002

  1. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia

    Nephrology Dialysis Transplantation, Vol. 17, Núm. 5, pp. 723-731

  2. Nutritional status in dialysis patients: A European consensus

    Nephrology Dialysis Transplantation, Vol. 17, Núm. 4, pp. 563-572

  3. Overweight and obesity as a nutritional issue in the dialysis population (multiple letters) [1]

    Nephrology Dialysis Transplantation

  4. Unexpected sensitivity of nonobese diabetic mice with a disrupted poly(ADP-ribose) polymerase-1 gene to streptozotocin-induced and spontaneous diabetes

    Diabetes, Vol. 51, Núm. 5, pp. 1470-1476

2001

  1. Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice

    Diabetes, Vol. 50, Núm. 12, pp. 2874-2878